Multicentric investigations of the role in the disease severity of accelerated phospholipid changes in COVID-19 patient airway
- 14 May 2024
- journal article
- research article
- Published by Elsevier in Microbes and Infection
- Vol. 26 (5-6) , 105354
Abstract
No abstract availableKeywords
Funding Information
- Fondation Air Liquide
This publication has 39 references indexed in Scilit:
- Alterations of Lipid Profile in COVID-19: A Narrative ReviewCurrent Problems in Cardiology, 2022
- COVID-19 ARDS: a review of imaging features and overview of mechanical ventilation and its complicationsEmergency Radiology, 2021
- COVID-19 pneumonia: different respiratory treatments for different phenotypes?Intensive Care Medicine, 2020
- Type IIA Secreted Phospholipase A2 in Host Defense against Bacterial InfectionsTrends in Immunology, 2020
- Novel functions of phospholipase A2s: OverviewBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2019
- Phospholipase A2 catalysis and lipid mediator lipidomicsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2019
- Emerging roles of secreted phospholipase A2 enzymes: The 3rd editionBiochimie, 2014
- Phospholipase A2 subclasses in acute respiratory distress syndromeBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2009
- Roles and regulation of secretory and lysosomal acid sphingomyelinaseCellular Signalling, 2009
- Ceramide-Enriched Membrane Domains in Infectious Biology and Development2008